Clinical trial
The Role of the Oral Microbiome in Carotid Atherosclerosis: Investigating in a Cross-sectional Study the Microbial Influence on Plaque Development and Vulnerability Based on Biobank Data
NCT07296965 is registered in ClinicalTrials.gov with Semmelweis University Heart and Vascular Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Role of the Oral Microbiome in Carotid Atherosclerosis: Investigating in a Cross-sectional Study the Microbial Influence on Plaque Development and Vulnerability Based on Biobank Data
- Lead sponsor
- Semmelweis University Heart and Vascular Center
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- November 1, 2025
- Completion date
- November 1, 2029
- Enrollment
- 200 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
atherosclerosis cardiovascular disease, atherosclerosis of artery, carotid artery diseases, carotid artery plaque, periodontitis